Evidence map›Paper›PMID 25030480›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2014

Tissue-engineered microenvironment systems for modeling human vasculature.

Anna Tourovskaia, Mark Fauver, Gregory Kramer, Sara Simonson, Thomas Neumann

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. HumanBioactive materials · 2026
    Article
  4. Engineering in vitro vascular microsystems.Microsystems & nanoengineering · 2025
    Review
  5. Article
  6. Bioengineering vascularization.Development (Cambridge, England) · 2024
    Review
  7. Article
  8. A Cell Pre-Wrapping Seeding Technique for Hydrogel-Based Tubular Organ-On-A-Chip.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The extracellular matrix mechanics in the vasculature.Nature cardiovascular research · 2023
    Review
  14. Review
  15. Integration of immune cells in organs-on-chips: a tutorial.Frontiers in bioengineering and biotechnology · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anna TourovskaiaNortis, Inc., Seattle, WA 98195, USA.
Mark FauverNortis, Inc., Seattle, WA 98195, USA.
Gregory KramerNortis, Inc., Seattle, WA 98195, USA.
Sara SimonsonNortis, Inc., Seattle, WA 98195, USA.
Thomas NeumannNortis, Inc., Seattle, WA 98195, USA neumann@nortisbio.com.
Nortis (United States) · US

Funding

Using iPSCs to model patient outcomes in nephrotic syndromeUH3TR000504 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2014 to 2016
$6.1M
A Tissue Engineered Human Kidney Microphysiological SystemUH2TR000504 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2012 to 2013
$2.1M
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug TestR43HL107040 · NHLBI · VISIONGATE, INC. · PI NEUMANN, THOMAS · 2011 to 2011
$202k
Development of an organotypic in-vitro model of the blood-brain barrierR43NS070440 · NINDS · VISIONGATE, INC. · PI NEUMANN, THOMAS · 2010 to 2010
$191k
Development of a Vascularized In-Vitro Model of the Tumor MicroenvironmentR43CA144469 · NCI · VISIONGATE, INC. · PI NEUMANN, THOMAS · 2010 to 2010
$188k
NCATS NIH HHS 1UH2TR000504-01NCATS NIH HHS UH2 TR000504NCATS NIH HHS UH3 TR000504NCI NIH HHS 1R43CA144469-01NCI NIH HHS R43 CA144469NHLBI NIH HHS 1R43HL107040-01A1NHLBI NIH HHS R43 HL107040NINDS NIH HHS 1R43NS070440-01NINDS NIH HHS R43 NS070440
6 · The paper itself

Abstract

The high attrition rate of drug candidates late in the development process has led to an increasing demand for test assays that predict clinical outcome better than conventional 2D cell culture systems and animal models. Government agencies, the military, and the pharmaceutical industry have started initiatives for the development of novel in-vitro systems that recapitulate functional units of human tissues and organs. There is growing evidence that 3D cell arrangement, co-culture of different cell types, and physico-chemical cues lead to improved predictive power. A key element of all tissue microenvironments is the vasculature. Beyond transporting blood the microvasculature assumes important organ-specific functions. It is also involved in pathologic conditions, such as inflammation, tumor growth, metastasis, and degenerative diseases. To provide a tool for modeling this important feature of human tissue microenvironments, we developed a microfluidic chip for creating tissue-engineered microenvironment systems (TEMS) composed of tubular cell structures. Our chip design encompasses a small chamber that is filled with an extracellular matrix (ECM) surrounding one or more tubular channels. Endothelial cells (ECs) seeded into the channels adhere to the ECM walls and grow into perfusable tubular tissue structures that are fluidically connected to upstream and downstream fluid channels in the chip. Using these chips we created models of angiogenesis, the blood-brain barrier (BBB), and tumor-cell extravasation. Our angiogenesis model recapitulates true angiogenesis, in which sprouting occurs from a "parent" vessel in response to a gradient of growth factors. Our BBB model is composed of a microvessel generated from brain-specific ECs within an ECM populated with astrocytes and pericytes. Our tumor-cell extravasation model can be utilized to visualize and measure tumor-cell migration through vessel walls into the surrounding matrix. The described technology can be used to create TEMS that recapitulate structural, functional, and physico-chemical elements of vascularized human tissue microenvironments in vitro.

Indexed as

Microfluidic Analytical TechniquesNeoplasmsTissue EngineeringBlood-Brain BarrierCapillariesCell Culture TechniquesCell Line, TumorCoculture TechniquesEndothelial CellsFemaleHumansMaleNeovascularization, Pathologicbody-on-chipmicroenvironmentMicrofluidic devicemicrophysiological systemmicrovasculatureorgan-on-chiptissue engineering

Identifiers

PMID25030480
PMCPMC4469377
OpenAlexW2099161811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.